Filing Flows › Agilent Technologies (A) › Q2 FY26 › vs Q1 FY26
Agilent Technologies (A) Q2 FY26 vs Q1 FY26 (quarter over quarter)
Agilent Technologies's revenue rose $37.0M (+2%) from $1.8B in Q1 FY26 to $1.8B in Q2 FY26. The biggest changes: Life Sciences and Diagnostics Markets +$53.0M (+8%); Applied Markets −$17.0M (-5%); Agilent CrossLab +$1.0M (+0.1%). Operating margin 21.7% against 19.6% (+2.1 pts).
Agilent Technologies, Q2 FY26: revenue $1.8B (+10% year over year), operating margin 21.7%, net earnings $339M, operating cash flow $277M. The chart draws each line against Q1 FY26, the increases inside each band.
Margins
| Q2 FY26 | Q1 FY26 | Change | |
|---|---|---|---|
| Operating margin | 21.7% | 19.6% | +2.1 pts |
| Net margin | 18.5% | 17.0% | +1.5 pts |
| Free cash flow margin | 11.0% | 9.7% | +1.2 pts |
Every line
| Line | Q2 FY26 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Agilent CrossLab | $759M | $758M | $1.0M | +0.1% |
| Life Sciences and Diagnostics Markets | $732M | $679M | $53.0M | +8% |
| Applied Markets | $344M | $361M | −$17.0M | -5% |
| Revenue | $1.8B | $1.8B | $37.0M | +2% |
| Other income, net | $9.0M | $11.0M | −$2.0M | -18% |
| Operating profit | $399M | $353M | $46.0M | +13% |
| Costs & expenses | $1.4B | $1.4B | −$9.0M | -0.6% |
| Pre-tax earnings | $408M | $364M | $44.0M | +12% |
| Cost of revenue | $845M | $852M | −$7.0M | -0.8% |
| Research & development | $126M | $117M | $9.0M | +8% |
| SG&A | $465M | $476M | −$11.0M | -2% |
| Net earnings | $339M | $305M | $34.0M | +11% |
| Income tax | $69.0M | $59.0M | $10.0M | +17% |
| Depreciation & amortization | $67.0M | $67.0M | $0 | 0% |
| Share-based compensation | $32.0M | $41.0M | −$9.0M | -22% |
| Working capital & other | $161M | $145M | $16.0M | +11% |
| Operating cash flow | $277M | $268M | $9.0M | +3% |
| Free cash flow (OCF − capex) | $201M | $175M | $26.0M | +15% |
| Capital expenditures | $76.0M | $93.0M | −$17.0M | -18% |
Questions
How much did Agilent Technologies's revenue grow quarter over quarter in Q2 FY26?
Agilent Technologies's revenue rose $37.0M (+2%) from $1.8B in Q1 FY26 to $1.8B in Q2 FY26.
What drove Agilent Technologies's revenue change in Q2 FY26?
Life Sciences and Diagnostics Markets +$53.0M (+8%); Applied Markets −$17.0M (-5%); Agilent CrossLab +$1.0M (+0.1%).